Back
Citizens Financial Group Vs. Kymera Therapeutics Industry Stock Comparison
Sell
22
CFG
Citizens Financial Group
Last Price:
34.66
Seasonality Move:
-3.93%
Sell
45
KYMR
Kymera Therapeutics
Last Price:
33.60
Seasonality Move:
34.28%
Sell
22
Citizens Financial Group (CFG)
is a Sell
Is Citizens Financial Group a Buy, Sell or Hold?
- The current Citizens Financial Group [CFG] share price is $34.66. The Score for CFG is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- CFG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $33.52. The Score for KYMR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- KYMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CFG Stock Price Chart
What is Citizens Financial Group's stock price today?
-
The Citizens Financial Group share price today is $34.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CFG is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $33.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight selling pressure.
CFG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 42.98 | Sell |
| Chaikin Money Flow: | -2579705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.9 - 36.4) | Sell |
| Bollinger Bands (100): | (31.99 - 35.43) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 39.11 | Sell |
| Chaikin Money Flow: | -120938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.14 - 37.56) | Sell |
| Bollinger Bands (100): | (31.65 - 40.45) | Sell |
CFG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.97 | Sell |
| 20-day SMA: | 35.78 | Sell |
| 50-day SMA: | 35.01 | Sell |
| 200-day SMA: | 30.68 | Buy |
| 8-day EMA: | 35.63 | Sell |
| 20-day EMA: | 35.63 | Sell |
| 50-day EMA: | 34.89 | Sell |
| 200-day EMA: | 32.51 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.92 | Sell |
| 20-day SMA: | 36.2 | Sell |
| 50-day SMA: | 36.62 | Sell |
| 200-day SMA: | 27.16 | Buy |
| 8-day EMA: | 34.84 | Sell |
| 20-day EMA: | 35.61 | Sell |
| 50-day EMA: | 36.05 | Sell |
| 200-day EMA: | 31.12 | Buy |
Citizens Financial Group Earnings Growth & CFG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.62 per share, and an increase next year of $0.78 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.31 per share.
Citizens Financial Group Technical Analysis
| May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||